Johnson and Johnson Archives | Northwest Public Broadcasting

Half Of All U.S. Adults Are Now Fully Vaccinated Against COVID-19

By NPR News May 25, 2021

Maryland National Guard Brig. Gen. Janeen Birckhead greets soldiers last week at a mobile vaccine clinic in Wheaton, Md.

The U.S. COVID-19 vaccination program has gone from zero to 50% in less than six months. As of Tuesday afternoon, the Biden administration said, half of the country's adults are now fully vaccinated against the coronavirus. Continue Reading Read More

U.S. Lifts Pause In Use Of J&J Vaccine After Vote By Expert Panel

By NPR News April 23, 2021

Bottles of the single-dose Johnson & Johnson COVID-19 vaccine await transfer into syringes for administering last month in Los Angeles. CREDIT: Frederic J. Brown/AFP via Getty Images

The Food and Drug Administration and the Centers for Disease Control and Prevention announced Friday after the panel voted that the vaccine is safe and effective at preventing COVID-19, and its benefits outweigh the known risks. Continue Reading Read More

FDA Inspection Finds Numerous Problems At Facility Intended To Make J&J Vaccine

By NPR News April 22, 2021

The Emergent BioSolutions Bayview Campus plant in Baltimore has stopped producing vaccine material following an FDA inspection that found numerous problems. The plant was slated to become part of the Johnson & Johnson COVID-19 vaccine production process. Tasos Katopodis/Getty Images

Peeling paint. Cracked buckets. Employees dragging unsealed bags of medical waste. Procedures ignored. Inadequately trained staff. All of these were problems noted by U.S. Food and Drug Administration inspectors at the Emergent BioSolutions factory in Baltimore – a facility that is intended to produce materials for the Johnson & Johnson COVID-19 vaccine. Read More

What You Need To Know: 6 Reported Blood Clot Cases In 7 Million From Johnson & Johnson Vaccine

By NPR News April 14, 2021

syringe going into a vial of COVID-19 vaccine

The Centers for Disease Control and Prevention says the blood clots are extremely rare but that it is reviewing the cases. The agency says it expects this pause to last for "a matter of days." Continue Reading What Read More

U.S. Recommends Pausing Use Of Johnson & Johnson Vaccine Over Blood Clot Concerns

By NPR News April 13, 2021

The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention have recommended a pause in the use of the Johnson & Johnson COVID-19 vaccine, shown here in a hospital in Denver. CREDIT: David Zalubowski/AP

The U.S. Centers for Disease Control and Prevention and the Food and Drug Administration said Tuesday they are recommending a "pause" in the use of the single-dose Johnson & Johnson COVID-19 vaccine out of an "abundance of caution" while a review of reports of rare, potentially dangerous blood clots is conducted. Read More

Johnson & Johnson Says Contractor Botched Part Of Vaccine Production

By NPR News April 1, 2021

An Emergent BioSolutions facility in Baltimore on Thursday. CREDIT: Tasos Katopodis/Getty Images

Johnson & Johnson is reporting a setback in its effort to produce tens of millions of COVID-19 vaccine doses, saying a contract production plant in Baltimore produced an ingredient that failed quality control tests. The material was made by Emergent BioSolutions, according to Johnson & Johnson. Read More

CDC Says It’s Safe For Vaccinated People To Do These Activities, Should Continue Masking In Public

By NPR News March 8, 2021

Kristin May, an EMT with the Seattle Fire Dept., gives the first dose of the Moderna COVID-19 vaccine to a patient at a City of Seattle community COVID-19 testing and vaccination clinic in Seattle's Rainier Beach neighborhood in February 2021. CREDIT: Ted S. Warren/AP

The new guidance is specific to freedoms that vaccinated people can resume in their own homes, but the agency warns that everyone – even those who are vaccinated – should continue to follow recommended guidelines in public settings, including masking. Read More

1 Shot Or 2 Shots? ‘The Vaccine That’s Available To You — Get That’

By NPR News March 5, 2021

Boxes containing vials of the Janssen COVID-19 vaccine sit in a container before being transported to a refrigeration unit at Louisville Metro Health and Wellness headquarters on March 4 in Louisville, Ky. The FDA approved the third COVID-19 vaccine on Feb. 27. CREDIT: Jon Cherry/Getty Images

As the newest coronavirus vaccine makes its debut, the American public has a new set of deliberations before walking into their vaccine clinic — go with the new arrival or stick with the two vaccines that have already gone into the arms of more than 50 million Americans? Read More

Some U.S. Faith Leaders Express ‘Moral Concerns’ About Johnson & Johnson Vaccine

By NPR News March 4, 2021

A health care worker holds a vial of the Johnson & Johnson COVID-19 vaccine at South Shore University Hospital in Bay Shore, N.Y., on Wednesday. CREDIT: via Getty Images

Unlike the Pfizer-BioNTech and Moderna vaccines, the Johnson & Johnson vaccine was produced in part through the use of cell lines derived from an aborted human fetus. In a statement released this week, leaders of the U.S. Conference of Catholic Bishops said that this feature of the vaccine raises questions about its permissibility. Read More

FDA Authorizes Johnson & Johnson’s One-Shot COVID-19 Vaccine

By NPR News February 27, 2021

A health care worker holds a vial of the Johnson & Johnson COVID-19 vaccine at Klerksdorp Hospital in Klerksdorp, South Africa, on Feb. 18. CREDIT: Phill Magakoe via Getty Images

A third COVID-19 vaccine is on the way, and this one requires only one shot for immunization. The Food and Drug Administration authorized Johnson & Johnson's vaccine for emergency use Saturday, a day after a panel of advisers to the agency voted unanimously (22-0) in its favor. Read More

Why The Johnson & Johnson Vaccine Has Gotten A Bad Rap — And Why That’s Not Fair

By NPR News February 22, 2021

Kurtis Smith gives the Moderna coronavirus vaccine to a resident at Red Hook Neighborhood Senior Center in Brooklyn, N.Y., on Monday. CREDIT: Michael M. Santiago/Getty Images

In clinical trials, the Johnson & Johnson vaccine appears to be 66% effective at preventing moderate to severe cases of COVID-19 — compared to about 95% for Moderna and Pfizer. That has some people wondering if they should avoid the Johnson & Johnson vaccine. Absolutely not, says Dr. Ashish Jha, dean of the Brown University School of Public Health. Read More

Johnson & Johnson Data Show Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19

By NPR News January 29, 2021

Prepared COVID-19 Pfizer-BioNTech vaccine syringes are seen at Edward Hospital in Naperville, Ill., Thursday, Dec. 17, 2020. Illinois received about 43,000 doses in its first shipment of a COVID-19 vaccine Monday as health officials reported another 103 coronavirus deaths statewide. Most of the shots will be distributed to local health care centers for health care workers, according to Illinois Gov. J.B. Pritzker's office. CREDIT: Nam Y. Huh/AP

The study was conducted in the U.S., Latin America and South Africa. The vaccine did better at preventing disease in the U.S. – 72% — and less well in South Africa – 57% efficacy. The efficacy seen in Latin America was 66%. Read More

Johnson & Johnson Stops Selling Talc-Based Baby Powder In U.S. And Canada

By NPR News May 19, 2020

The company said demand has declined "fueled by misinformation around the safety of the product and a constant barrage of litigation advertising." Lawsuits allege the powder causes cancer. Continue Reading Johnson & Johnson Stops Read More

Several Drug Companies Considering Large Settlements To Resolve Opioid Suits

By NPR News August 28, 2019

Purdue Pharma and other health care giants are discussing potential deals with authorities that could resolve thousands of lawsuits they're facing over the U.S. opioid epidemic. Drew Angerer/Getty Images

Confronted with a torrent of lawsuits across the U.S., several major drug companies are in discussions with authorities to resolve thousands of opioid-related suits filed against them. A government source close to the negotiations tells NPR that Purdue Pharma, Johnson & Johnson, Endo International and Allergan are looking to cut deals. Read More